Observational study to understand how blood products are given during large amount of bleeding during cancer surgery
Not Applicable
- Conditions
- Health Condition 1: O- Medical and SurgicalHealth Condition 2: C00-D49- Neoplasms
- Registration Number
- CTRI/2022/06/043009
- Lead Sponsor
- Tata Memorial Hospital Parel
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Closed to Recruitment of Participants
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
All adult patients aged 18 -90 years undergoing elective cancer surgery who have blood loss more than 50 % of expected blood volume.
Exclusion Criteria
Exclusion criteria : 1. Patients undergoing liver resection surgery
2. Patients with abnormal preoperative coagulation tests
3. Patients with preoperative platelet count less than 150000/cmm
4. Patients with preoperative liver dysfunction
5. Patients with ASA physical status III or above 6. Pregnancy
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Incidence of patients receiving clotting factors and /or platelet transfusion and volume of blood loss at which clotting factors and/or platelets are transfused.Timepoint: intraoperatively
- Secondary Outcome Measures
Name Time Method Incidence of coagulopathy before starting correction with clotting and/or platelets transfusionTimepoint: Intraoperaively